Case Capital & Law Firm Financing for Plaintiff Firm Owners

A contingency-fee firm pays for its cases years before it gets paid for them. Experts, depositions, records, staff, marketing and rent all go out on the firm's schedule; fees come in on the court's schedule, the defendant's schedule and the client's schedule. Every financing decision an owner makes sits inside that mismatch.

That is why the useful question is rarely "how much can I get?" It is "which kind of capital matches this spend, this timing and this downside?" A large commitment on the wrong structure can be more dangerous than a smaller one on the right structure, and no capital at all is sometimes the right answer.

Counsel Leverage, based in New Orleans, works with owners and managing partners of contingency-fee plaintiff firms on that fit question. This page lays out how we think about it: what counts as law firm financing, how the common structures differ, who owes what when a case loses or drags, how to compare cost across unlike offers, and when to fix the practice before adding leverage. Much of what follows is market orientation. It describes categories you will encounter from banks, specialty lenders and litigation funders so you can compare them intelligently. It is not a statement that Counsel Leverage offers each one, and reading it is not an application, an approval or a commitment. The broader picture of how capital, technology and advisory fit together lives on our overview; this page stays on the financing decision.

Ready to talk now? Request a capital-fit conversation through the contact form on this site. Bring a short, nonconfidential description of the need—the brief outlined near the end of this page—and nothing privileged.

Law Firm Financing Funds the Practice or Its Case Work—not a Client's Living Expenses

Law firm financing is capital obtained by a law firm for firm operations, litigation expenditures or other business purposes permitted by the agreement. It is distinct from consumer pre-settlement funding, which is advanced to an injured client for personal needs and repaid from the client's share of a recovery. Firm financing can be structured as a loan, a credit facility, a case-cost arrangement or a participation in future fees, and the repayment obligation depends on the specific contract—not on the label.

The cleanest way to keep the two apart is to look at three things rather than the marketing name:

• Who receives the money. Firm financing goes to the firm. Consumer advances go to the plaintiff.
• What it may be spent on. Firm financing is spent on the practice: case expenses, payroll, marketing, technology, expansion. Consumer advances cover the client's rent, medical bills and living costs while a case is pending.
• Where repayment comes from. Firm financing is repaid from firm revenue, from fees on specified cases, or from a defined set of case proceeds. Consumer advances are repaid from the client's portion of a settlement or judgment.

"Case capital" is a descriptive phrase, not a standardized product. In one agreement it means capital tied to a specific case or group of cases with repayment limited to fees from those cases. In another it means a loan with a personal guarantee that happens to be earmarked for case costs. The words tell you the purpose; only the document tells you the obligation.

The reason any of this exists is timing. A firm can hold a strong docket and still be short of cash, because case spending is front-loaded and fee receipts are back-loaded and uncertain. Financing does not shorten that gap. At best it lets you carry the gap without starving the cases or the operation. That distinction—carrying a gap versus fixing one—runs through everything below. The mechanics of single-case and third-party structures are covered in more depth under litigation funding for law firms.

Match Case Costs, Operating Cash and Multi-Case Needs to Different Financing Questions

Owners often arrive at the financing conversation with a product name already in mind: "I need a line of credit," or "I want portfolio financing." Start instead with the purpose, the repayment source and how much delay the firm can absorb. The product follows from those answers, and the labels describe different things. A line of credit describes how you access money: draws up to an agreed limit under the facility's terms, which may be revolving or non-revolving. A single-disbursement term loan is a different access structure, not a type of line of credit. Case-cost financing describes what you spend it on. Portfolio financing describes the scope of what secures or repays it (many cases rather than one). A single facility can be all three at once.

The table compares the structures you are most likely to be offered. It describes commonly seen market arrangements; availability, eligibility and terms are specific to each provider and each contract. For background on how the third-party funding market has been described and how limited the public data is, see the U.S. Government Accountability Office report on third-party litigation financing (GAO-23-105210), which is a market overview as of its publication date, not a rate source.

A few practical notes on using the table:

Bank and specialty credit is the conventional path. A bank typically prices off the firm's financials and expects scheduled payments through a slow fee year; a specialty lender may underwrite the docket itself and price and secure the facility accordingly. In either case, whether the owner is personally exposed is a term to read, not a feature of the category. Revolving access—the law firm line of credit most owners ask about first—is genuinely useful for smoothing operating cash, but a lender's tolerance for delayed receipts is expressed through covenants and payment schedules, not through patience.

Case-cost financing answers a narrow question: how do I pay for the experts, depositions and discovery this case needs without draining operating cash? The contract question is whether that money is owed back if the case loses. Some arrangements say yes; some say only from fees on that case. The expense categories, approval mechanics and repayment variations are laid out under financing case costs.

Case-linked and portfolio funding can move some outcome risk to the funder in exchange for a share of fees or a return that grows with time—but only to the extent the contract actually says so. The trade is real, and so is the price. Single-case structures are covered under litigation funding for law firms; multi-case obligations, concentration issues and cross-collateral questions are covered under portfolio financing.

Mass tort financing is not a separate legal product so much as a practice-specific evaluation. Mass tort dockets have long timelines, heavy front-end acquisition and records costs, bellwether-driven uncertainty and concentration in a handful of litigations. Any of the structures above can be applied to a mass tort practice; the diligence questions about timing and concentration simply matter more. That evaluation is developed under mass tort financing.

None of these categories carries universal eligibility. A firm that fits one lender's profile may be outside another's, and the same structure can be priced and secured very differently by two providers.

Recourse vs Non-Recourse: Compare Recovery Rights, Not Just the Label

Recourse describes which assets or parties a financing counterparty may pursue for repayment. Non-recourse financing generally limits recovery to specified sources—usually fees or proceeds from identified cases—but only to the extent the agreement says so. The label by itself does not establish that there is no personal guarantee, no collateral beyond the cases, no exceptions for breach or misrepresentation, and no obligation if proceeds arrive late or fall short. Those are separate terms, and each has to be read.

Owners understandably hear "non-recourse" and translate it to "if we lose, we owe nothing and I'm not personally exposed." Sometimes that is exactly what the document provides. Often it is narrower. Treat these as independent questions and get an answer to each from the actual agreement:

Cross-collateralization and portfolio-level recovery rights are not inherently unfair—they are how funders price a group of cases as a group—but they are contract-review questions, not assumptions.

This section is meant to give you the selection criteria. Clause-level treatment, how loss and delay scenarios play out under different drafting, and how to frame these points in negotiation are handled under recourse versus non-recourse financing. Any actual agreement should be reviewed by counsel familiar with the law of the relevant jurisdiction before signature.

Law Firm Financing Rates Are Only One Part of the Cost Decision

This page does not publish a rate range for law firm financing, and you should be skeptical of any page that does without a specific product and date attached. Rates in this market depend on structure, security, docket quality, firm history and the provider's own cost of capital, and a quoted "rate" on a fee-participation arrangement is not comparable to an interest rate on a bank line.

The way to compare unlike offers is to translate each one into total contractual cash obligations under the same assumptions, then compare the timing and restrictions that come with each. Where applicable, the items that generate cost include:

• Interest on drawn balances, and whether it accrues simply or compounds
• Fees: origination, commitment, unused-line, monitoring, servicing, legal, extension and exit fees
• Participation economics: a percentage of fees, a multiple of capital deployed, or a return that steps up with time—and whether the greater of several formulas applies
• Minimum payment or minimum return provisions that apply even if proceeds are modest
• Repayment priority: whether the counterparty is paid before the firm sees any fee on a case, and how that interacts with existing liens or co-counsel splits
• Early-exit or prepayment terms: whether paying off early saves money, costs money or is not permitted

Not every agreement contains every item. The point is to check for each and to ask what amount actually generates charges. A committed line that costs nothing until drawn is a different animal from a facility that accrues on the full commitment from day one. Ask, in writing, what the firm owes if it draws nothing, draws half, or draws everything.

Then run the comparison under consistent assumptions about draws and receipts—including a scenario where receipts arrive later than planned and a scenario where they arrive smaller. Time-based escalators that look tolerable in a base case can dominate the cost in a two-year slip. An annualized "effective rate" can be a useful summary of those cash flows, but only if the timing and calculation assumptions behind it are shown, and it should always sit next to the absolute dollars the firm would repay under each scenario.

Itemize two further costs so each can be judged on its own. The first is advisor or intermediary compensation—what Counsel Leverage or anyone else is paid, and by whom. If a fee is mandatory to obtain the financing, it belongs in the all-in cost of that financing; if it pays for a service you can decline, show it separately. The second is any separately contracted implementation or consulting work, which is an operating expense, not a cost of capital. The worksheet approach, the formulas behind participation structures and the mechanics of repayment waterfalls are developed under compare financing economics.

Before Financing Growth or Marketing, Test Whether the Firm Can Use the Capital Well

Financing solves a timing problem. It does not solve a conversion problem, a capacity problem or a cash-discipline problem, and adding obligations on top of any of those makes the underlying problem more expensive. Before borrowing for growth, marketing or payroll, separate the two:

• A temporary liquidity gap looks like a firm whose cases are developing on plan, whose intake is producing qualified clients at a known cost, and whose fee receipts are simply later than the expense curve. Capital that bridges that gap is doing its job.
• A persistent operating shortfall looks like a firm whose costs exceed receipts across cycles, whose intake produces volume but not signed and viable matters, or whose docket keeps aging without resolving. Capital here buys time, but time alone does not change the trajectory, and the carrying cost compounds while you wait.

Nobody can diagnose which one you have from a web page. The questions below are the ones worth answering before the financing conversation, not after.

Financing marketing spend

Lead counts are the wrong denominator. Marketing capital should be judged on the chain that follows a lead: how many become qualified, how many qualified become signed, how many signed become cases the firm can actually develop, and what each of those cases will cost to work up before a fee is possible. As a hypothetical, a budget that doubles inbound calls into an intake team already dropping half of them has not bought growth; it has bought missed calls and a larger records-and-expert bill down the road. Test intake capacity and qualified-client conversion first; the operating side of that is covered under intake optimization.

Financing payroll and growth hires

New staff are continuing expenses. The question is not whether the firm can afford them under the plan; it is whether the firm can still afford them if anticipated fees move twelve months to the right. If the honest answer is no, the hire is not a growth decision yet—it is a bet on timing, and financing turns it into a bet with interest.

Alternatives worth evaluating

None of these is a recommendation for your firm; each is an option that belongs on the same sheet as the financing proposal:

• Retained earnings and owner distributions deferred for a defined period
• Conventional credit, if the firm qualifies and can carry scheduled payments through a slow year
• Staged spending: funding one campaign, one hire or one case-expense program at a time and releasing the next tranche only when the first clears defined milestones
• Operational improvement first: tightening intake, records and inventory management so the same dollars produce more signed, workable cases

The cash-flow modeling that supports these decisions lives under cash-flow and growth planning; the ongoing question of where firm capital should go is treated under law firm capital strategy; and execution of the growth plan itself is covered under plaintiff law firm growth and scaling.

Protect Client Authority, Lawyer Independence and Confidential Information

A capital provider or advisor never directs litigation or settlement decisions. That is not a courtesy; it is the boundary that makes firm financing compatible with the lawyer's obligations. The client decides whether to settle. The lawyer exercises independent professional judgment. The counterparty receives financial reporting. Any term that blurs those lines needs to come out or be reviewed by ethics counsel before the firm signs.

Most U.S. jurisdictions pattern their rules on the ABA Model Rules of Professional Conduct, but the Model Rules are not themselves binding; each state's adopted rules are, and they differ. Louisiana's Rules of Professional Conduct are adopted by the Louisiana Supreme Court. Which rules govern a given arrangement can turn on where the lawyers are licensed, where the cases are pending and the tribunal's own requirements—a choice-of-law question, not a single-state assumption. Bar ethics opinions, even from the issuing jurisdiction's bar, are generally advisory rather than adopted rules. Use the Model Rule numbers below as a map for what to verify under the rules that actually apply:

• Client settlement authority (Model Rule 1.2 pattern). No consent right, veto, "consultation" requirement or economic penalty in the financing agreement may operate to shift the settle-or-try decision away from the client.
• Independence and fee sharing (Model Rule 5.4 pattern). Arrangements in which a non-lawyer's return is tied to legal fees raise fee-sharing questions in some jurisdictions. New York City Bar Formal Opinion 2018-5 addressed funders' contingent interests in legal fees under New York's rules; it is jurisdiction-specific and advisory, and should be read in full and checked for later developments rather than treated as a nationwide answer. Have the structure reviewed under the rules that apply to you.
• Conflicts (Model Rules 1.7 and 1.8 patterns). Does the financing create a conflict between the firm's interest in repayment and the client's interest in the outcome? Are there existing liens, prior funders, referral fees or co-counsel interests that the new counterparty's priority would collide with?
• Handling of funds (Model Rule 1.15 pattern). How will settlement proceeds move? Before any payment to a financing counterparty, assess who owns each portion of the proceeds, what liens attach, whether any amount is disputed, and what trust-account duties apply. The agreement's payment mechanics must fit those duties, not the other way around.
• Confidentiality and privilege (Model Rule 1.6 pattern and applicable privilege law). Diligence requests for case material implicate both. The two are not the same thing, and neither is solved by a nondisclosure agreement.

On that last point, the practical rule is: start with nonconfidential summaries and escalate only through a reviewed process. Before any case-level material moves, assess whether the client's informed consent is required, minimize what is shared, confirm how it is stored and who can see it, and get a jurisdiction-specific view on whether disclosure to a funder risks waiver of privilege or work-product protection. An NDA controls what the recipient may do with the information; it does not, on its own, determine how a court will treat the disclosure. Some forums also impose disclosure obligations regarding third-party funding; check the rules of the courts where your cases are pending.

Distinguish reporting from control. It is normal for a counterparty to receive periodic status on financed cases, aggregate inventory data and firm financials. It is not normal—and should not be accepted—for that reporting to come with approval rights over strategy, experts, settlement ranges or the decision to try a case. How single-case funders structure reporting is covered under litigation funding for law firms; how these protections interact with recourse terms is covered under recourse versus non-recourse financing.

Clarify Counsel Leverage's Role Before Evaluating an Engagement

An experienced owner's first question to anyone talking about capital should be: whose money is this, who am I contracting with, and how do you get paid? Ask it of us and of every other party at the table, and expect written answers before you spend time on diligence.

Counsel Leverage's own offering is narrower than the market survey above. We work with select plaintiff-firm opportunities on case capital, with the option of paired operational implementation, and we are not a source of every category this page describes. For any specific matter, the following belong in writing before evaluation proceeds:

• Role. Whether Counsel Leverage is acting as a capital provider, an arranger introducing outside capital, an advisor to the firm, or some combination—and whether that role differs across capital and implementation work.
• Capital source and contracting entities. Who makes the capital decision, which entity signs with the firm, and whether any intermediary or affiliated entity participates in the transaction or its economics.
• Compensation. What Counsel Leverage earns on the capital, whether any of it is paid by a provider rather than the firm, and how advisory or implementation services are priced separately.
• Exclusivity and conflicts. Whether any term restricts you from talking to other providers, and whether we hold interests that could sit across from yours.

This page deliberately does not publish a capital range, an approval timeline, a non-recourse promise or an availability statement. Those depend on the specific opportunity and the documents that would govern it, and they belong in a written proposal you and your counsel can read—not in marketing copy.

The judgment on this page about timing, intake, records and what leverage does to a contingency practice is offered as a decision framework, not as a promise about any particular engagement. The wider picture of who Counsel Leverage is and how capital, technology and advisory fit together is on our overview. How capital and operational capability are combined in a single engagement, and how the two scopes are kept distinct, is explained under capital plus operational capability.

Capital with AI Implementation Requires a Separate Scope and a Measurable Operating Need

Some owners come to the capital conversation because they want to spend better, not just spend more: the intake team is triaging by hand, records requests are managed in spreadsheets, and nobody can produce a current view of the inventory without a week of work. Capital and implementation can address complementary needs—one funds the case work, the other improves the machine that does it—but they are different services and should be scoped, staffed and priced separately. Not every financing engagement includes implementation work, and implementation does not guarantee faster or larger recoveries.

Areas where an implementation assessment is often worth running in a plaintiff practice:

• Intake routing and qualification support — consistent capture, faster follow-up, cleaner handoff to the legal team, with a human making the sign/decline call
• Records workflows — tracking requests, organizing what comes back, producing first-draft chronologies for a nurse or paralegal to verify
• Inventory reporting — a live view of case status, aging, expenses incurred and upcoming deadlines across the docket

Each of these is listed as something to evaluate, not as a delivered outcome. Any claim that a workflow improved should rest on a baseline measurement, a defined measurement period, an honest accounting of the human-review effort the tool still requires, and an operating objective it was meant to hit. Ask for all four before accepting the claim.

Two safeguards do not bend regardless of how the work is funded. Lawyers supervise: generative tools draft, summarize and sort, and a responsible attorney or trained staff member checks the output before it touches a client, a court or a decision. ABA Formal Opinion 512 sets out competence, confidentiality, communication, supervision and fee considerations for generative AI under the Model Rules; it is advisory, and your state's rules and guidance control. And confidentiality governs the tooling: where data goes, who the vendor is, what the vendor may retain or train on, and how access is controlled are contract and security questions to settle before any case material enters a system. Technology does not transfer legal or settlement judgment to an advisor any more than capital does.

Selecting and executing implementation is covered under AI implementation for plaintiff firms and AI consulting and implementation; the detailed policy, security and vendor-governance framework is under AI governance and safeguards; and how a combined engagement is structured is explained under capital plus operational capability.

Start with a Nonconfidential Capital Brief—not a Case-File Upload

The first conversation should cost you an hour of thinking, not a data-room build. It should also be safe: nothing privileged, nothing that identifies a client, nothing that would need consent before it left your office.

What to bring

A short, nonconfidential capital brief covering:

1. Intended use — case costs on specific matters, operating cash, marketing, hires, technology, refinancing an existing facility, or a mix
2. Approximate capital need and timing — a range and when the money would actually be spent
3. Broad practice mix — the types of matters and, at an aggregate level, how many are pre-suit, in litigation or approaching resolution
4. Existing financing and constraints — current lenders or funders, liens on fees or receivables, personal guarantees outstanding, covenants that limit new debt
5. Your own view of the downside — what happens to the plan if fee receipts arrive a year later than expected

A sensible sequence

1. Clarify the need. Is this a timing gap or an operating gap, and what is the money for?
2. Assess plausible structures. Which of the categories on this page fit the purpose, repayment source and timing tolerance—including conventional credit or no new financing.
3. Identify information gaps. What would a counterparty need to see before writing terms, and what does the firm need to see before it could evaluate them.
4. Establish disclosure safeguards. Before any case-level material moves: consent, minimization, secure sharing, and a jurisdiction-specific view on privilege.
5. Evaluate written terms. With your own counsel and accountant, under the same draw and delay assumptions for every offer.

That sequence separates a fit conversation from underwriting, from legal review and from a binding commitment. Each is a distinct step and none is implied by the one before it.

What later diligence may require

If the conversation moves forward, a capital provider will typically want some combination of firm financial statements, aggregate case-inventory data, a schedule of existing obligations and liens, co-counsel and referral arrangements that affect fee priority, and the firm's own assumptions about receipt timing. Treat this as a description of what is commonly requested, not a universal approval checklist; requirements vary by provider and structure.

Do not send client names, medical records, litigation strategy, expert work product or unredacted case files through an ordinary inquiry form or email. If that material is ever needed, it should move only after step four above is complete. Preparing the firm-side numbers is covered under cash-flow and growth planning; preparing to evaluate terms is covered under compare financing economics.

How to Read This Page

Statements here fall into three categories, and they carry different weight.

Market comparisons describe structures commonly seen in law firm and litigation finance. They orient the decision; they do not describe any specific product's availability, pricing or terms. Provider descriptions are product-specific and should be verified directly with each provider.

Contractual statements about recourse, security, cost and repayment are framed as questions to put to an actual agreement because the agreement, not this page, governs the obligation. Nothing here substitutes for review of proposed documents by counsel qualified in the relevant jurisdiction.

Ethics and legal statements point to the texts an owner should read or have counsel read: the ABA Model Rules cited above, the Louisiana Supreme Court's Rules of Professional Conduct, New York City Bar Formal Opinion 2018-5 and ABA Formal Opinion 512. Model rules and ethics opinions are not adopted law; state rules and tribunal requirements are what bind. Current statutory developments on litigation funding should be checked in their official text, with attention to whether they address consumer legal funding, commercial funding, firm financing or all three.

Where this page declines to state a capital range, a timeline, a compensation structure or an operating result, that is deliberate: those facts belong in written engagement documents rather than in a page that may be read out of context.

Request a Capital-Fit Conversation About Your Firm's Next Funding Decision

If you are weighing a financing decision—case costs on a matter that is getting expensive, operating cash through a slow fee year, a marketing or hiring push, a mass tort docket that needs carrying, or a refinancing of something you signed under pressure—the next step is a conversation about fit.

Request a capital-fit conversation through the contact form on this site. Bring the nonconfidential brief described above: intended use, approximate need and timing, broad practice mix, existing obligations and your own view of the downside. The initial conversation is a fit discussion based on a general description of the opportunity; it is not underwriting, legal review or a commitment. We will work through whether a timing gap or an operating gap is driving the need, which structures plausibly fit, what a counterparty would need to see, and what you should evaluate before signing anything. Counsel Leverage's role and compensation for your matter are set out in writing before any further step.

Expect one of several honest outcomes: further evaluation of a specific structure, a suggestion that conventional credit or staged spending fits better, a recommendation to shore up intake or cash discipline before adding leverage, or a conclusion that there is no suitable engagement right now. None of these outcomes is an approval, a rate quote or a commitment, and none is promised on any timeline.

Do not include privileged material, client identities or case files in an initial inquiry.

If you are not ready to talk, the pages most owners read next are recourse versus non-recourse financing, compare financing economics and capital plus operational capability.